PGHAX Mutual Fund

PGHAX Mutual Fund

NAV$76.19
See how much of PGHAX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Feb 28, 2026

Net Assets
-
Expense Ratio
0.70%
Dividend Yield (Current)
0.46%
Holdings
119
Inception Date
Jun 1, 2020
Fund Family
Putnam Investments
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+3.40%
1 Year+25.38%
3 Year+9.15%
5 Year+6.69%
10 Year+9.26%

Asset Allocation

Stocks: 98.24%
Bonds: 0.15%
Other: 1.60%
See how much of PGHAX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co.11.34%
JNJJohnson & Johnson - Common8.91%
ABBVAbbvie Inc.5.94%
NOVN:SMNovartis Ag – Class N5.53%
MRKMerck & Company Inc5.33%
Top 10 Concentration: 57.52%Report Date: Feb 28, 2026
Download all 119 holdings for PGHAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.46%
Frequency
Annually
Latest Distribution
$5.80
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

PGHAX Mutual Fund Overview

PGHAX Mutual Fund (Putnam Global Health Care Fund Class R6) is managed by Putnam Investments. PGHAX expense ratio is 0.70%, holding 119 positions across sectors including Health Care. Inception date: 2020-06-01.

PGHAX performance shows a YTD return of 3.40%. The 1-year return is 25.38% and the 5-year return is 6.69%. PGHAX dividend yield stands at 0.46%, paid annually.

PGHAX top holdings include Eli Lilly & Co. (11.3%), Johnson & Johnson - Common (8.9%), Abbvie Inc. (5.9%), Novartis Ag – Class N (5.5%), Merck & Company Inc (5.3%). Go to all PGHAX holdings, PGHAX sectors, or PGHAX dividends.

PGHAX can be compared against other funds. Use PGHAX overlap to find shared positions, or PGHAX vs another fund for a side-by-side view. PGHAX alternatives are available via the screener, along with tax-loss harvesting opportunities.